Artivion, Inc. (AORT)
NYSE: AORT · Real-Time Price · USD
26.31
-0.81 (-2.99%)
Aug 10, 2026, 4:00 PM EDT - Market closed
Artivion Revenue
Artivion had revenue of $125.76M in the quarter ending June 30, 2026, with 11.32% growth. This brings the company's revenue in the last twelve months to $471.47M, up 16.40% year-over-year. In the year 2025, Artivion had annual revenue of $441.33M with 13.59% growth.
Revenue (ttm)
$471.47M
Revenue Growth
+16.40%
P/S Ratio
2.72
Revenue / Employee
$261,930
Employees
1,800
Market Cap
1.28B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 441.33M | 52.79M | 13.59% |
| Dec 31, 2024 | 388.54M | 34.53M | 9.75% |
| Dec 31, 2023 | 354.00M | 40.22M | 12.82% |
| Dec 31, 2022 | 313.79M | 14.95M | 5.00% |
| Dec 31, 2021 | 298.84M | 45.61M | 18.01% |
| Dec 31, 2020 | 253.23M | -23.00M | -8.32% |
| Dec 31, 2019 | 276.22M | 13.38M | 5.09% |
| Dec 31, 2018 | 262.84M | 73.14M | 38.55% |
| Dec 31, 2017 | 189.70M | 9.32M | 5.17% |
| Dec 31, 2016 | 180.38M | 34.48M | 23.63% |
| Dec 31, 2015 | 145.90M | 1.26M | 0.87% |
| Dec 31, 2014 | 144.64M | 3.88M | 2.75% |
| Dec 31, 2013 | 140.76M | 9.05M | 6.87% |
| Dec 31, 2012 | 131.72M | 12.09M | 10.11% |
| Dec 31, 2011 | 119.63M | 2.98M | 2.56% |
| Dec 31, 2010 | 116.65M | 4.96M | 4.44% |
| Dec 31, 2009 | 111.69M | 6.63M | 6.31% |
| Dec 31, 2008 | 105.06M | 10.30M | 10.87% |
| Dec 31, 2007 | 94.76M | 13.45M | 16.54% |
| Dec 31, 2006 | 81.31M | 12.03M | 17.36% |
| Dec 31, 2005 | 69.28M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| QuidelOrtho | 2.67B |
| Enovis | 2.30B |
| Integra LifeSciences Holdings | 1.65B |
| CONMED | 1.37B |
| Tandem Diabetes Care | 1.04B |
| Lumexa Imaging Holdings | 1.03B |
| Inspire Medical Systems | 898.74M |
| Alphatec Holdings | 815.05M |
AORT News
- 3 days ago - Artivion price target lowered to $39.20 from $42 at Ladenburg - TheFly
- 3 days ago - Artivion price target raised to $39 from $36 at Canaccord - TheFly
- 4 days ago - Artivion reports Q2 non-GAAP EPS 13c, consensus 10c - TheFly
- 4 days ago - Artivion repeats 2026 revenue $480M-$496M, consensus $486.23M - TheFly
- 4 days ago - Artivion Earnings Call Transcript: Q2 2026 - Transcripts
- 4 days ago - Artivion Earnings release: Q2 2026 - Filings
- 4 days ago - Artivion Slides: Q2 2026 - Filings
- 4 days ago - Artivion Quarterly report: Q2 2026 - Filings